Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Revenue

In the year 2023, Clearside Biomedical had annual revenue of $8.23M with 519.89% growth. Revenue in the quarter ending December 31, 2023 was $6.35M with 1,822.73% year-over-year growth.

• Revenue (ttm): $8.23M
• Revenue Growth: +519.89%
• P/S Ratio: 11.99
• Revenue / Employee: $274,200
• Employees: 30
• Market Cap: 98.63M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.23M	6.90M	519.89%
Dec 31, 2022	1.33M	-28.25M	-95.51%
Dec 31, 2021	29.58M	21.68M	274.65%
Dec 31, 2020	7.89M	5.72M	263.28%
Dec 31, 2019	2.17M	2.14M	7,143.33%
Dec 31, 2018	30.00K	-315.00K	-91.30%
Dec 31, 2017	345.00K	-175.00K	-33.65%
Dec 31, 2016	520.00K	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.